BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30788559)

  • 1. Extended abdominopelvic MRI versus CT at the time of adnexal mass characterization for assessing radiologic peritoneal cancer index (PCI) prior to cytoreductive surgery.
    Gadelhak B; Tawfik AM; Saleh GA; Batouty NM; Sobh DM; Hamdy O; Refky B
    Abdom Radiol (NY); 2019 Jun; 44(6):2254-2261. PubMed ID: 30788559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings.
    Garcia Prado J; González Hernando C; Varillas Delgado D; Saiz Martínez R; Bhosale P; Blazquez Sanchez J; Chiva L
    Eur J Radiol; 2019 Dec; 121():108696. PubMed ID: 31683251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients.
    Engbersen MP; Van' T Sant I; Lok C; Lambregts DMJ; Sonke GS; Beets-Tan RGH; van Driel WJ; Lahaye MJ
    Eur J Radiol; 2019 May; 114():146-151. PubMed ID: 31005166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
    Mikkelsen MS; Petersen LK; Blaakaer J; Marinovskij E; Rosenkilde M; Andersen G; Bouchelouche K; Iversen LH
    Eur J Surg Oncol; 2021 Aug; 47(8):2134-2141. PubMed ID: 33812768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
    Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
    Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET/MRI for the preoperative diagnosis and staging of peritoneal carcinomatosis: a prospective multireader pilot study.
    Vietti Violi N; Gavane S; Argiriadi P; Law A; Heiba S; Bekhor EY; Babb JS; Ghesani M; Labow DM; Taouli B
    Abdom Radiol (NY); 2023 Dec; 48(12):3634-3642. PubMed ID: 36308554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival.
    Avesani G; Arshad M; Lu H; Fotopoulou C; Cannone F; Melotti R; Aboagye E; Rockall A
    Radiol Med; 2020 Aug; 125(8):770-776. PubMed ID: 32239470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist.
    Torkzad MR; Casta N; Bergman A; Ahlström H; Påhlman L; Mahteme H
    J Surg Oncol; 2015 May; 111(6):746-51. PubMed ID: 25580825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of radiologic- laparoscopic peritoneal carcinomatosis categorization in the prediction of surgical outcome.
    Abdalla Ahmed S; Abou-Taleb H; Ali N; M Badary D
    Br J Radiol; 2019 Aug; 92(1100):20190163. PubMed ID: 31112412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures.
    Low RN; Barone RM; Lucero J
    Ann Surg Oncol; 2015 May; 22(5):1708-15. PubMed ID: 25201499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index.
    Diaz-Gil D; Fintelmann FJ; Molaei S; Elmi A; Hedgire SS; Harisinghani MG
    Abdom Radiol (NY); 2016 Nov; 41(11):2196-2202. PubMed ID: 27338731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.
    Klumpp BD; Schwenzer N; Aschoff P; Miller S; Kramer U; Claussen CD; Bruecher B; Koenigsrainer A; Pfannenberg C
    Abdom Imaging; 2013 Feb; 38(1):64-71. PubMed ID: 22476333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The accuracy of multi-detector computed tomography and laparoscopy in the prediction of peritoneal carcinomatosis index score in primary ovarian cancer.
    Ahmed SA; Abou-Taleb H; Yehia A; El Malek NAA; Siefeldein GS; Badary DM; Jabir MA
    Acad Radiol; 2019 Dec; 26(12):1650-1658. PubMed ID: 31101436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
    Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
    Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the peritoneal carcinomatosis index with CT and MRI.
    Dohan A; Hoeffel C; Soyer P; Jannot AS; Valette PJ; Thivolet A; Passot G; Glehen O; Rousset P
    Br J Surg; 2017 Aug; 104(9):1244-1249. PubMed ID: 28376270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography.
    Zhang J; Mironov S; Hricak H; Ishill NM; Moskowitz CS; Soslow RA; Chi DS
    J Comput Assist Tomogr; 2008; 32(4):533-40. PubMed ID: 18664838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resectability of Peritoneal Carcinomatosis: Learnings from a Prospective Cohort of 533 Consecutive Patients Selected for Cytoreductive Surgery.
    Mohkam K; Passot G; Cotte E; Bakrin N; Gilly FN; Ledochowski S; Bernard L; Valette PJ; Glehen O; Rousset P
    Ann Surg Oncol; 2016 Apr; 23(4):1261-70. PubMed ID: 26628435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
    van 't Sant I; van Eden WJ; Engbersen MP; Kok NFM; Woensdregt K; Lambregts DMJ; Shanmuganathan S; Beets-Tan RGH; Aalbers AGJ; Lahaye MJ
    Br J Surg; 2019 Mar; 106(4):491-498. PubMed ID: 30353920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative assessment of peritoneal carcinomatosis of colorectal origin.
    Dohan A; Hobeika C; Najah H; Pocard M; Rousset P; Eveno C
    J Visc Surg; 2018 Sep; 155(4):293-303. PubMed ID: 29602696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of
    Jónsdóttir B; Ripoll MA; Bergman A; Silins I; Poromaa IS; Ahlström H; Stålberg K
    Cancer Imaging; 2021 Apr; 21(1):34. PubMed ID: 33849649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.